Immunogen Inc (IMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,051 | -44,372 | -75,760 | -53,386 | -29,088 |
| Depreciation Amortization | 551 | 2,101 | 1,569 | 1,045 | 529 |
| Accounts receivable | -5,452 | 8,455 | 3,446 | 8,183 | 6,694 |
| Accounts payable and accrued liabilities | 3,802 | -819 | -1,028 | 2,161 | -649 |
| Other Working Capital | -4,043 | -4,557 | 5,004 | 5,237 | 5,126 |
| Other Operating Activity | -5,428 | -39,428 | -20,386 | -19,748 | -10,927 |
| Operating Cash Flow | $-44,621 | $-78,620 | $-87,155 | $-56,508 | $-28,315 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -893 | 509 | 611 | 1,382 | 1,405 |
| Investing Cash Flow | $-893 | $509 | $611 | $1,382 | $1,405 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 34,778 | 195,742 | 98,536 | 98,407 | 97,984 |
| Financing Cash Flow | $34,778 | $195,742 | $98,536 | $98,407 | $97,984 |
| Beginning Cash Position | 293,856 | 176,225 | 176,225 | 176,225 | 176,225 |
| End Cash Position | 283,120 | 293,856 | 188,217 | 219,506 | 247,299 |
| Net Cash Flow | $-10,736 | $117,631 | $11,992 | $43,281 | $71,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,621 | -78,620 | -87,155 | -56,508 | -28,315 |
| Capital Expenditure | -893 | -917 | -815 | -44 | -21 |
| Free Cash Flow | -45,514 | -79,537 | -87,970 | -56,552 | -28,336 |